PFM Health Sciences
Crossover fundSan Francisco · Pre-Seed–Series A · 10 people tracked
Not to be confused with PFM Health Sciences (Crossover fund · San Francisco, US)
Find your way into PFM Health Sciences
Sign up to see every warm intro you have to PFM Health Sciences
- Paths you didn't know you had: your email and LinkedIn already hold routes to the PFM Health Sciences team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
PFM Health Sciences focuses on the healthcare sector, believing the industry is in a powerful, long-term innovation cycle producing transformative investment opportunities. The firm takes a specialist, bottom-up, fundamental approach, leveraging secular growth, domain expertise, and demographic trends. It values partnering with companies that deliver measurable and sustainable impact on health outcomes while being responsible stewards of institutional capital. Risk management and portfolio construction aim to dampen volatility while offering an attractive return-to-risk profile. The firm emphasizes flexibility to invest across the capital structure in both public and private companies within biopharma, medical technology, life science, and healthcare services.
Source: firm website, verified Oct 11, 2026.
Team · 10 people
from the firm's website & public directoriesFounding partner of Partner Fund Management (2004) and the firm's sole managing partner since 2020, when it was renamed PFM Health Sciences. He previously analyzed biotech at Pequot Capital and Andor Capital and began his career at J.P. Morgan Investment Management. He holds a B.S. in Economics from the University of Pennsylvania and is a CFA charterholder.
Joined PFM in 2007 and leads trading. He previously managed credit trading strategies at Barclays Global Investors and worked at Standish Mellon Asset Management. He holds a B.S. in Economics-Finance from Bentley College and is a CFA charterholder.
Rejoined PFM in 2023 and serves as General Counsel and Chief Compliance Officer. He previously held regulatory compliance roles at IQ-EQ, Greyline Partners, ACA Compliance Group and F-Squared Investments. He holds a business degree from the University of Delaware and a JD from Suffolk University Law School.
Joined PFM in 2024 after serving as a senior analyst covering global healthcare with a pharmaceuticals focus at Elliott Management. He previously worked in private equity at GI Partners and in investment banking at Credit Suisse, and holds a B.A. in Economics from Princeton University.
Joined PFM in 2007 and leads business development. He was previously a managing director in U.S. equity sales at Merrill Lynch. He holds a degree from the University of New Mexico and an MBA from UCLA's Anderson School of Management.
Joined PFM in 2014 and serves as Chief Financial Officer. He was previously a tax manager at Burr Pilger Mayer and co-founder and CFO of Cerbae LLC. He holds a B.A. in Economics from UCLA.
Joined PFM in 2025 after managing a diversified large-cap healthcare portfolio at Freestone Grove Partners. He was previously a partner and co-head of healthcare at Glenview Capital Management and worked in private equity at Water Street Healthcare Partners and banking at Barclays. He holds B.A. degrees in Economics and History from Duke University.
Joined PFM in 2021 after serving as a senior associate on the biotechnology investing team at New Enterprise Associates. He previously worked in healthcare M&A advisory at Lazard and holds degrees in Economics (Wharton) and Biology from the University of Pennsylvania.
Joined PFM in 2012 after roles at Catapult Partners/Millennium and as an analyst and sector head at Argus/Sivik Healthcare. He previously held equity research positions at UBS and Smith Barney, and holds a B.A. in Economics from Delhi University and an MBA from the College of William and Mary.
Frequently asked questions
- What stage does PFM Health Sciences invest at?
- PFM Health Sciences invests at the Pre-Seed, Seed, Series A stages.
- What sectors does PFM Health Sciences focus on?
- PFM Health Sciences focuses on AI & Machine Learning, Biotech, Consumer, Crypto & Web3, Digital Health, Fintech, Healthtech, Medical Devices, SaaS.
- Where is PFM Health Sciences located?
- PFM Health Sciences is headquartered in San Francisco, US.
Similar investors
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Khosla Ventures is a venture capital firm that backs bold, early-stage, technology-driven companies across deep tech and other sectors, providing hands-on 'venture assistance' to help founders build category-defining businesses.
OMERS Ventures is a venture capital firm that invests in founders globally, with investment teams based in New York, Palo Alto, and Toronto.
Colle Capital Partners is an opportunistic, early-stage technology venture fund investing globally across a broad range of technology sectors.
Alumni Ventures (AV) is a venture capital firm that co-invests alongside lead VCs in startups, backing founders with capital and access to a large investor and operator community.
.jpeg)